With results identifying the aberrant expression of miR‐374 and TYR in melanoma, interests aroused considering their effects on the biological behaviours of melanoma tumour cells following delivery of miR‐374 mimic, miR‐374 inhibitor and siRNA‐TYR. The gene discussed is TYR; the disease is neoplasm.